gw856553
Showing 1 - 11 of 11
Pulmonary Disease, Chronic Obstructive Trial in Edinburgh (GW856553)
Completed
- Pulmonary Disease, Chronic Obstructive
- GW856553
-
Edinburgh, United KingdomGSK Investigational Site
Aug 3, 2017
Depressive Disorder, Major Trial in Worldwide (GW856553, Placebo)
Completed
- Depressive Disorder, Major
- GW856553
- Placebo
-
Hoffman Estates, Illinois
- +20 more
Oct 11, 2017
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GW856553, Placebo, Seretide)
Completed
- Pulmonary Disease, Chronic Obstructive
- GW856553
- +2 more
-
Tallinn, Estonia
- +30 more
Aug 17, 2017
Acute Coronary Syndrome Trial in Worldwide (GW856553, Placebo)
Completed
- Acute Coronary Syndrome
- GW856553
- Placebo
-
Anchorage, Alaska
- +107 more
Nov 2, 2017
Pain, Neuropathic Trial in Worldwide (GW856553, PLACEBO)
Completed
- Pain, Neuropathic
- GW856553
- PLACEBO
-
Broadmeadow, New South Wales, Australia
- +22 more
Feb 15, 2017
Arthritis, Rheumatoid Trial in Romania, Russian Federation, Spain (GW856553)
Completed
- Arthritis, Rheumatoid
- GW856553
-
Bucharest, Romania
- +14 more
May 11, 2015
Arthritis, Rheumatoid Trial in Worldwide (GW856553)
Completed
- Arthritis, Rheumatoid
- GW856553
-
Plovdiv, Bulgaria
- +16 more
Nov 1, 2012
Atherosclerosis, Cardiovascular Disease Trial in Dallas (GW856553)
Completed
- Atherosclerosis
- Cardiovascular Disease
- GW856553
-
Dallas, TexasGSK Investigational Site
May 31, 2012
Healthy Subjects, Dyslipidaemias, Dyslipidaemia Trial in Cambridge, Cardiff, London (GW856553)
Completed
- Healthy Subjects
- +2 more
- GW856553
-
Cambridge, United Kingdom
- +2 more
May 31, 2012
Pulmonary Disease, Chronic Obstructive, COPD (COPD) Trial in Hannover, Grosshansdorf, Berlin (GW856553)
Completed
- Pulmonary Disease, Chronic Obstructive
- Chronic Obstructive Pulmonary Disease (COPD)
- GW856553
-
Hannover, Niedersachsen, Germany
- +2 more
May 31, 2012
COPD (COPD), Rheumatoid Arthritis, Atherosclerosis Trial in Tacoma (GW856553)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- +2 more
- GW856553
-
Tacoma, WashingtonGSK Investigational Site
Oct 13, 2010